Telmisartan Inhibits NSCLC A549 Cell Proliferation and Migration by Regulating the PI3K/AKT Signaling Pathway

Oncology Letters - Greece
doi 10.3892/ol.2018.8002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Downregulation of TM7SF4 Inhibits Cell Proliferation and Metastasis of A549 Cells Through Regulating the PI3K/AKT/mTOR Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

Correction: CLCA4 Inhibits Bladder Cancer Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/AKT Pathway

Oncotarget
Oncology
2019English

MKRN2 Inhibits Migration and Invasion of Non-Small-Cell Lung Cancer by Negatively Regulating the PI3K/Akt Pathway

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2018English

Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway

Frontiers in Oncology
Cancer ResearchOncology
2020English

PAQR3 Inhibits Proliferation via Suppressing PI3K/AKT Signaling Pathway in Non-Small Cell Lung Cancer

Archives of Medical Science
Medicine
2018English

Diosgenin Inhibits Cell Proliferation of Primary Human Thyrocytes via Downregulation of PI3K/Akt Signaling Pathway

Tropical Journal of Pharmaceutical Research
PharmacologyPharmaceutical Science
2018English

Rapamycin Inhibits Proliferation and Apoptosis of Retinoblastoma Cells Through PI3K/AKT Signaling Pathway

Oncology Letters
Cancer ResearchOncology
2020English

MicroRNA-21 Promotes Glioma Cell Proliferation and Inhibits Senescence and Apoptosis by Targeting SPRY1 via the PTEN/PI3K/AKT Signaling Pathway

CNS Neuroscience and Therapeutics
PsychiatryMental HealthPhysiologyPharmacology
2018English

FOXC1 Silencing Promotes A549 Cell Apoptosis Through Inhibiting the PI3K/AKT/hedgehog/Gli2 Signaling Pathway

RSC Advances
ChemistryChemical Engineering
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy